AgriBiotix AS
AgriBiotix AS is a five-person Norwegian biotechnology spin-off from NMBU and NIBIO developing beneficial microorganisms for sustainable biocontrol and antimicrobial bacteriocins. It sells research-grade peptides and contract research services to agriculture, forest nursery, greenhouse, and pharmaceutical research customers.
- Company typePrivate
- Founded2022
- HeadquartersÅs, Norway
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What AgriBiotix AS does
AgriBiotix AS is a small Norwegian biotechnology company founded in 2022 as a spin-off from research conducted at the Norwegian University of Life Sciences (NMBU) and the Norwegian Institute of Bioeconomy Research (NIBIO) at Ås, Norway. Operating with five employees, the company develops sustainable biocontrol products based on beneficial microorganisms with antifungal and plant growth-promoting activity, and identifies and purifies antimicrobial bacteriocins from probiotic bacteria. Its addressable end markets span agricultural crop protection, Norwegian forest nurseries, greenhouse vegetable production, and pharmaceutical antimicrobial research.
The company's portfolio comprises three commercial research-grade antimicrobial peptides (Micrococcin P1, Garvicin KS, and Enterocin K1) sold in milligram quantities through its website with publicly listed tiered pricing, plus BioGran — an in-development biocontrol product containing indigenous Norwegian bacteria targeting fungal disease on Norway spruce seedlings. Underlying capabilities include bioprospecting for indigenous Norwegian bacterial strains, a curated biobank of pesticide-sensitive and -resistant pathogenic fungi (Botrytis cinerea, Pythium, Sclerotinia sclerotiorum, Rhizoctonia solani), established greenhouse trial protocols for cucumber, lettuce, potato, strawberry, and Norway spruce, and proprietary mouse skin infection models using luciferase-tagged MRSA for in vivo antimicrobial testing. Notably, no patents or trademarks are disclosed in the available source material.
AgriBiotix operates a sales-led go-to-market with two revenue streams: contract research services (including mouse infection model testing, greenhouse trials, and antimicrobial compound evaluation) and direct sales of research-grade antimicrobial peptides. Distribution is via direct website sales for the global peptide market and direct client engagement for Norwegian and regional contract research. The company has secured non-dilutive funding through partnerships with Grofondet and RFF Viken, and maintains a core co-development relationship with NIBIO alongside commercial trial work with greenhouse operator Guren Gartneri.
AgriBiotix AS firmographics
Firmographics- Name
- AgriBiotix AS
- Legal name
- AgriBiotix AS
- Website
- https://agribiotix.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AgriBiotix AS is a five-person Norwegian biotechnology spin-off from NMBU and NIBIO developing beneficial microorganisms for sustainable biocontrol and antimicrobial bacteriocins. It sells research-grade peptides and contract research services to agriculture, forest nursery, greenhouse, and pharmaceutical research customers.
- Ownership category
- akta.pro rank
AgriBiotix AS industry classification
Industry- Product category
- Agricultural Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pesticide and Other Agricultural Chemical Manufacturing (32532), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Agricultural Chemicals (2870)
- akta.pro primary industry
- Microbial Biofungicides (AFABAEAB)
- akta.pro secondary industries
- Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK), Bacteriocins & Biopreservatives (Nisin, Natamycin, Pediocin) (AFAJAFAG)
Keywords
Where AgriBiotix AS is headquartered
LocationHeadquarters
- HQ city
- Ås
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
AgriBiotix AS business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Contract Research Services: Provides contract research services including mouse skin infection models for testing antimicrobial compounds, greenhouse and biocontrol trials, and antimicrobial peptide testing
- Antimicrobial Peptide Sales: Direct sales of research-grade antimicrobial peptides including Micrococcin P1, Garvicin KS, and Enterocin K1 with tiered pricing based on quantity
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Enterocin K1 - Leaderless bacteriocin for research use |
| Unit Pricing | Pay-as-you-go | Micrococcin P1 - Thiopeptide for research use |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
AgriBiotix AS product offering
Product offeringCore offering
AgriBiotix develops and sells research-grade antimicrobial bacteriocins (Micrococcin P1, Garvicin KS, Enterocin K1, and Enterocin hybrid H1) purified from probiotic bacteria, and provides contract research services including luciferase-tagged MRSA mouse skin infection models and greenhouse biocontrol trials. The company is also developing BioGran, a biofungicide based on indigenous Norwegian bacteria for biological control of fungal diseases on Norway spruce seedlings in forest nurseries.
Product overview
AgriBiotix AS is a biotechnology company developing sustainable biocontrol products and discovering antimicrobial bacteriocins. The product portfolio includes three commercial antimicrobial peptide research products (Micrococcin P1, Garvicin KS, and Enterocin K1) sold for research purposes, contract research services including mouse infection model testing and greenhouse trials, and the in-development BioGran biocontrol product. The company also offers custom antimicrobial peptide and lipopeptide contract research services.
Differentiator
Problem solved
Functional benefit
Products and services
- Micrococcin P1 Multicyclic thiopeptide with broad activity against Gram-positive bacteria including MRSA, VRE, Listeria monocytogenes, Clostridium difficile, M. tuberculosis, and P. falciparum; sold to research institutions and pharmaceutical companies for in vitro and in vivo antimicrobial studies.
- Garvicin KS (garKS) Multipeptide bacteriocin composed of three small peptides (gakA, gakB, gakC) of 32-34 amino acids each, with potent activity against multidrug-resistant Listeria, VRE, MRSA, lactococci, streptococci, and bacilli; sold for research use.
- Enterocin K1 (EntK1) Leaderless three-peptide bacteriocin highly potent against Enterococcus faecium including nosocomial multidrug-resistant isolates and VRE; heat-stable, protease-sensitive, and stable for at least 1 year at room temperature.
- Enterocin hybrid (H1) Hybrid bacteriocin with activity against Vancomycin-resistant E. faecium and Staphylococcus haemolyticus, available to research buyers.
- Mouse Skin Infection Model Services Contract research service using mouse skin infection models with Luciferase-tagged Methicillin-resistant Staphylococcus aureus (MRSA) for testing new antimicrobial compounds; enables visual inspection of infection progress without sacrificing animals. Targeted at pharmaceutical researchers and academic labs developing novel antimicrobials.
- Greenhouse and Biocontrol Trials Greenhouse and biocontrol trial services including plant growth experiments, plant infection trials, and pathogen infection studies with a biobank of pesticide-sensitive and resistant isolates of Botrytis cinerea, Pythium, Sclerotinia sclerotiorum, and Rhizoctonia solani. Established protocols for cucumber, lettuce, potato, strawberry, and Norway spruce.
- BioGran Biofungicide based on indigenous Norwegian beneficial bacteria for biological control of fungal diseases on seeds and young Norway spruce plants in forest nurseries. Prototype treatment reduced plant mortality from 94.9% to 10.9-13.8% after gray mold infection.
Quantifiable outcome
- 94.9% of untreated control plants die after gray mold infection; only 10.9-13.8% of plants treated with AgriBiotix prototype formulas die after infection
- +1 more outcomes
Companies that use AgriBiotix AS
Customer profileSegments4 records
Ideal customer profiles3 records
AgriBiotix AS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
AgriBiotix AS partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- NIBIO (Norwegian Institute of Bioeconomy Research)coreNIBIO collaborates with AgriBiotix on developing biological plant protection products, fertilizer products, and biostimulants. The company was established based on research from NIBIO at Ås.
- Guren GartneriminorGuren Gartneri collaborates on testing optimal combinations of insect frass and bacteria against natural fungal infections on cucumbers in commercial greenhouse settings.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
AgriBiotix AS competitors and assessment
Company assessmentBroad incumbents
- Pivot Bio: Pivot Bio develops microbial nitrogen solutions that replace synthetic fertilizers. Comparable agricultural biologicals company leveraging microbial discovery for crop inputs, though focused on nitrogen fixation rather than biocontrol.
- Indigo Ag: Indigo Ag develops microbial seed treatments and crop biologicals to improve plant health and yield. Larger incumbent with broader portfolio but comparable focus on beneficial microorganisms for sustainable agriculture.
- Novonesis: Novonesis (formed from Novozymes and Chr. Hansen merger) is the largest broad incumbent in microbial and enzyme solutions for agriculture, including biocontrol, biostimulants, and biological crop protection. Competes broadly with AgriBiotix's agricultural biologicals offerings.
- BioWorks, Inc. BioWorks manufactures biological control products including biofungicides and biostimulants for horticulture and agriculture. Competes with AgriBiotix in the same product categories (botanical and microbial biocontrol) but with established commercial scale.
- Certis Biologicals: Certis Biologicals is an established manufacturer of biological crop protection products including biofungicides (the direct category for BioGran). Broader portfolio and larger commercial scale than AgriBiotix, with overlapping product categories in biocontrol.
Direct peers
- BioConsortia: BioConsortia uses microbial discovery and directed selection to develop agricultural biological products including biostimulants and biocontrol. Comparable business model to AgriBiotix's approach of identifying beneficial microorganisms for plant health.
- Sound Agriculture: Sound Agriculture develops microbial and biochemical solutions to improve crop yields and nutrient use efficiency. Both companies share a focus on beneficial microorganisms for sustainable agriculture, though Sound Agriculture is more advanced commercially.
- Vestaron Corporation: Vestaron develops peptide-based biopesticides derived from natural sources for crop protection. Highly comparable to AgriBiotix's approach of using antimicrobial bacteriocin peptides as agricultural biocontrol agents, with similar dual focus on agriculture and pharmaceutical applications.
- AgBiome: AgBiome discovers and develops microbial solutions for crop protection using a GENESIS discovery platform that bioprospects beneficial microorganisms. Direct conceptual parallel to AgriBiotix's bioprospecting of Norwegian indigenous bacteria for biocontrol and plant health applications.
Emerging players
- Phare Bio: Phare Bio develops antimicrobial peptides using AI-driven discovery to combat drug-resistant bacteria. Comparable to AgriBiotix's antimicrobial peptide platform targeting AMR pathogens, though Phare focuses more on pharmaceutical applications.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
AgriBiotix AS social profiles
Digital presenceAgriBiotix AS financial estimates
Financial estimateRevenue estimate
Valuation estimate
AgriBiotix AS leadership team
Management profileNumber of profiles
Profiles3 records
AgriBiotix AS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AgriBiotix AS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AgriBiotix AS
What does AgriBiotix AS do?
AgriBiotix develops and sells research-grade antimicrobial bacteriocins (Micrococcin P1, Garvicin KS, Enterocin K1, and Enterocin hybrid H1) purified from probiotic bacteria, and provides contract research services including luciferase-tagged MRSA mouse skin infection models and greenhouse biocontrol trials. The company is also developing BioGran, a biofungicide based on indigenous Norwegian bacteria for biological control of fungal diseases on Norway spruce seedlings in forest nurseries.
Is AgriBiotix AS a public or private company?
AgriBiotix AS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AgriBiotix AS founded?
AgriBiotix AS was founded in 2022. It employs 1 to 10 people.
Where is AgriBiotix AS based?
AgriBiotix AS is headquartered in Ås, Norway, in the Europe region.
How does AgriBiotix AS make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are antimicrobial Peptide Sales.
Who are AgriBiotix AS's main competitors?
Broad incumbents on record are Pivot Bio, Indigo Ag, Novonesis, BioWorks, Inc. and Certis Biologicals. Direct peers are BioConsortia, Sound Agriculture, Vestaron Corporation and AgBiome. Phare Bio is listed as an emerging player.
Does AgriBiotix AS have an API?
No public API is recorded for AgriBiotix AS.
What industry is AgriBiotix AS in?
AgriBiotix AS's product category is Agricultural Biotechnology. Its primary akta.pro industry code is AFABAEAB, Microbial Biofungicides, with a secondary code of AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial). Its NAICS code is 541714 and its SIC code is 2870.